Clinical Trials Directory

Trials / Completed

CompletedNCT02190162

The Influence of Tantum Verde® on Recovery Following Tonsillectomy

A Prospective Double-blined Randomized Trial to Evaluate The Influence of Tantum Verde® on Recovery Following Tonsillectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Western Galilee Hospital-Nahariya · Other Government
Sex
All
Age
12 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the effects of Tantum Verde® for improving recovery following tonsillectomy Study design: A prospective double-blined randomized trial. Sample size: Thirty patients undergoing tonsillectomy who will be treated with Tantum Verde® Mouth wash solution, and a control group of 30 patients that will undergo tonsillectomy and will be treated with a placebo. The study will be conducted in the Departments Otolaryngology - Head and Neck Surgery in the Western Galilee Medical Center, Nahariya, Israel. Patients who are scheduled for tonsillectomy with or without adenoidectomy will be recruited for the study. They will sign the inform consent in one of two places: in the departments before the surgery or in the clinic in the visit before the surgery. The patients will be evaluated for their ability to gargle and spit water before the surgery, after which they will be assigned to either the treatment group who will get a solution of Tantum Verde or the control group who will receive saline with mint flavor, both in identicle bottles. Randomization will be done using a random number generator program. The patients will be asked to gargle and spit the solution they received three times a day for 30 seconds, for the following week after surgery.

Conditions

Interventions

TypeNameDescription
DRUGTantum Verde® mouthwash
OTHERPlacebo mouthwashMouthwash with placebo solution

Timeline

Start date
2014-07-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2014-07-15
Last updated
2018-10-02

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02190162. Inclusion in this directory is not an endorsement.